|
PCMT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.42019999596721E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.27079999248758E-09 |
| Normal-vs-Stage2 |
1.78583999999038E-05 |
| Normal-vs-Stage3 |
1.050200E-01 |
| Normal-vs-Stage4 |
2.159600E-02 |
| Stage1-vs-Stage2 |
9.168200E-01 |
| Stage1-vs-Stage3 |
8.936400E-02 |
| Stage1-vs-Stage4 |
2.167600E-01 |
| Stage2-vs-Stage3 |
1.471430E-01 |
| Stage2-vs-Stage4 |
2.572200E-01 |
| Stage3-vs-Stage4 |
8.011600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.57570003898189E-09 |
| Normal-vs-AfricanAmerican |
2.587000E-04 |
| Normal-vs-Asian |
1.321030E-01 |
| Caucasian-vs-AfricanAmerican |
1.135420E-01 |
| Caucasian-vs-Asian |
9.926000E-01 |
| AfricanAmerican-vs-Asian |
6.163800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.54839984856903E-10 |
| Normal-vs-Female |
6.444600E-03 |
| Male-vs-Female |
2.139700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.215010E-04 |
| Normal-vs-Extreme_Weight |
3.66660035666655E-10 |
| Normal-vs-Obese |
6.188100E-04 |
| Normal-vs-Extreme_Obese |
1.060120E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.579770E-01 |
| Normal_Weight-vs-Obese |
4.113000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.325600E-01 |
| Extreme_Weight-vs-Obese |
7.738600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.050000E-01 |
| Obese-vs-Extreme_Obese |
1.967620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.996600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.53240000034094E-07 |
| Normal-vs-Age(61-80Yrs) |
3.43049999518286E-09 |
| Normal-vs-Age(81-100Yrs) |
1.23839999999209E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.730390E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.123800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.539800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.557150E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.452210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.936400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.03320000333085E-08 |
| Normal-VS-Type2 PRCC |
1.06849999959024E-07 |
| Normal-VS-KIRP CIMP |
1.445830E-01 |
| Normal-VS-Unclassified PRCC |
1.53548999999309E-05 |
| Type1 PRCC-VS-Type2 PRCC |
9.059200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.25250000043908E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
7.780200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.95949999995493E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
8.627400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.76620000000139E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.07200000279917E-08 |
| Normal-vs-N1 |
4.916200E-01 |
| Normal-vs-N2 |
9.765300E-04 |
| N0-vs-N1 |
7.519500E-03 |
| N0-vs-N2 |
7.350200E-01 |
| N1-vs-N2 |
1.523230E-01 |
|
|
